Compare $KPTI vs $TPST | Chartloom

Compare

$KPTI vs $TPST

Karyopharm Therapeutics Inc · Tempest Therapeutics Inc

KPTI

Karyopharm Therapeutics Inc

TPST

Tempest Therapeutics Inc

Compare $KPTI vs $TPST

Comparing Karyopharm Therapeutics Inc and Tempest Therapeutics Inc

KPTIKaryopharm Therapeutics Inc

TPSTTempest Therapeutics Inc

KPTIKaryopharm Therapeutics Inc

Market cap

$14M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.10x

Rev growth (TTM)

6.8%

YTD performance

-91.6%

52W performance

-89.7%

FCF yield

-476.7%

TPSTTempest Therapeutics Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-6.3%

YTD performance

-74.2%

52W performance

-93.1%

FCF yield

-170.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KPTI

TPST

Detailed metrics comparison

KPTI

Karyopharm Therapeutics Inc

TPST

Tempest Therapeutics Inc

Market Cap

KPTI$14M

TPST$12M

Enterprise Value

KPTI$281M

TPST$11M

Price

KPTI$0.61

TPST$0.76

P/E Ratio

KPTIN/A

TPSTN/A

P/S Ratio

KPTI0.09x

TPST45.67x

EV/Sales

KPTI1.92x

TPST43.07x

EV/EBITDA

KPTI0.00x

TPST0.00x

P/B Ratio

KPTI0.36x

TPST16.67x

P/FCF Ratio

KPTIN/A

TPSTN/A

EV/FCF

KPTI-4.30x

TPST-0.55x

PEG Ratio

KPTIN/A

TPSTN/A

Forward P/E (NTM)

KPTIN/A

TPSTN/A

Forward P/S (NTM)

KPTI0.10x

TPSTN/A

Revenue (TTM)

KPTI$147M

TPST$0

Revenue Growth (YoY)

KPTI6.8%

TPST-6.3%

Forward Rev Growth

KPTI27.7%

TPST0.0%

Gross Margin (TTM)

KPTI95.9%

TPST0.0%

Operating Margin (TTM)

KPTI0.0%

TPST0.0%

EBITDA Margin (TTM)

KPTI-56.1%

TPST0.0%

Net Margin (TTM)

KPTI-153.3%

TPST0.0%

FCF Margin (TTM)

KPTI-44.6%

TPSTN/A

Net Income (TTM)

KPTI$-225M

TPST$-40M

FCF (TTM)

KPTI$-65M

TPST$-21M

EPS (TTM)

KPTI-$7.77

TPST-$2.66

ROE (TTM)

KPTI-18243.0%

TPST-72989.0%

ROA (TTM)

KPTI-20094.0%

TPST-29736.0%

ROIC (TTM)

KPTI-6632.0%

TPST-72989.0%

Cash

KPTI$55M

TPST$779K

Debt

KPTI$322M

TPST$0

Net Cash/Debt

KPTI$-267M

TPST$779K

Current Ratio (TTM)

KPTI0.79x

TPST0.38x

Quick Ratio (TTM)

KPTI0.71x

TPST0.27x

Debt/Equity (TTM)

KPTI3.78x

TPST0.00x

Debt/Assets (TTM)

KPTI0.0%

TPST0.0%

Interest Coverage (TTM)

KPTIN/A

TPSTN/A

Net Debt/EBITDA (TTM)

KPTI0.00x

TPST0.00x

Beta

KPTI1.14

TPST-1.61

52W Performance

KPTI-89.7%

TPST-93.1%

YTD Performance

KPTI-91.6%

TPST-74.2%

% from 52W High

KPTI-94.5%

TPST-93.8%

% from 52W Low

KPTI7.1%

TPST2.3%

Asset Turnover (TTM)

KPTI1.31x

TPST0.01x

FCF Yield (TTM)

KPTI-476.7%

TPST-170.7%

Earnings Yield (TTM)

KPTI-1639.3%

TPST-333.2%

Dividend Yield (TTM)

KPTIN/A

TPSTN/A

Rule of 40

KPTI-37.8

TPST-6.3

EV/GP/RG

KPTI0.07

TPSTN/A

Ticker research

View KPTI research View TPST research

Metric	KPTI Karyopharm Therapeutics Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$14M	$12M
Enterprise Value	$281M	$11M
Price	$0.61	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.09x	45.67x
EV/Sales	1.92x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.36x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.30x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.10x	N/A
Revenue & Growth
Revenue (TTM)	$147M	$0
Revenue Growth (YoY)	6.8%	-6.3%
Forward Rev Growth	27.7%	0.0%
Profitability
Gross Margin (TTM)	95.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-56.1%	0.0%
Net Margin (TTM)	-153.3%	0.0%
FCF Margin (TTM)	-44.6%	N/A
Net Income (TTM)	$-225M	$-40M
FCF (TTM)	$-65M	$-21M
EPS (TTM)	-$7.77	-$2.66
ROE (TTM)	-18243.0%	-72989.0%
ROA (TTM)	-20094.0%	-29736.0%
ROIC (TTM)	-6632.0%	-72989.0%
Financial Health
Cash	$55M	$779K
Debt	$322M	$0
Net Cash/Debt	$-267M	$779K
Current Ratio (TTM)	0.79x	0.38x
Quick Ratio (TTM)	0.71x	0.27x
Debt/Equity (TTM)	3.78x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.14	-1.61
52W Performance	-89.7%	-93.1%
YTD Performance	-91.6%	-74.2%
% from 52W High	-94.5%	-93.8%
% from 52W Low	7.1%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	1.31x	0.01x
FCF Yield (TTM)	-476.7%	-170.7%
Earnings Yield (TTM)	-1639.3%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	-6.3
EV/GP/RG	0.07	N/A
Ticker research	View KPTI research	View TPST research

Valuation

P/S Ratio

KPTI

0.09x

TPST

45.67x

EV/FCF

KPTI

-4.30x

TPST

-0.55x

Growth & revenue

Revenue Growth TTM

KPTI

6.8%

TPST

-6.3%

Forward Revenue Growth

KPTI

27.7%

TPST

0.0%

Profitability & performance

Gross Margin

KPTI

95.9%

TPST

0.0%

ROE

KPTI

-18243.0%

TPST

-72989.0%

FCF Yield %

TPST

-170.7%

KPTI

-476.7%

52-Week Performance

KPTI

-89.7%

TPST

-93.1%

Detailed metrics comparison

KPTI

Karyopharm Therapeutics Inc

TPST

Tempest Therapeutics Inc

Market Cap

KPTI$14M

TPST$12M

Enterprise Value

KPTI$281M

TPST$11M

Price

KPTI$0.61

TPST$0.76

P/E Ratio

KPTIN/A

TPSTN/A

P/S Ratio

KPTI0.09x

TPST45.67x

EV/Sales

KPTI1.92x

TPST43.07x

EV/EBITDA

KPTI0.00x

TPST0.00x

P/B Ratio

KPTI0.36x

TPST16.67x

P/FCF Ratio

KPTIN/A

TPSTN/A

EV/FCF

KPTI-4.30x

TPST-0.55x

PEG Ratio

KPTIN/A

TPSTN/A

Forward P/E (NTM)

KPTIN/A

TPSTN/A

Forward P/S (NTM)

KPTI0.10x

TPSTN/A

Revenue (TTM)

KPTI$147M

TPST$0

Revenue Growth (YoY)

KPTI6.8%

TPST-6.3%

Forward Rev Growth

KPTI27.7%

TPST0.0%

Gross Margin (TTM)

KPTI95.9%

TPST0.0%

Operating Margin (TTM)

KPTI0.0%

TPST0.0%

EBITDA Margin (TTM)

KPTI-56.1%

TPST0.0%

Net Margin (TTM)

KPTI-153.3%

TPST0.0%

FCF Margin (TTM)

KPTI-44.6%

TPSTN/A

Net Income (TTM)

KPTI$-225M

TPST$-40M

FCF (TTM)

KPTI$-65M

TPST$-21M

EPS (TTM)

KPTI-$7.77

TPST-$2.66

ROE (TTM)

KPTI-18243.0%

TPST-72989.0%

ROA (TTM)

KPTI-20094.0%

TPST-29736.0%

ROIC (TTM)

KPTI-6632.0%

TPST-72989.0%

Cash

KPTI$55M

TPST$779K

Debt

KPTI$322M

TPST$0

Net Cash/Debt

KPTI$-267M

TPST$779K

Current Ratio (TTM)

KPTI0.79x

TPST0.38x

Quick Ratio (TTM)

KPTI0.71x

TPST0.27x

Debt/Equity (TTM)

KPTI3.78x

TPST0.00x

Debt/Assets (TTM)

KPTI0.0%

TPST0.0%

Interest Coverage (TTM)

KPTIN/A

TPSTN/A

Net Debt/EBITDA (TTM)

KPTI0.00x

TPST0.00x

Beta

KPTI1.14

TPST-1.61

52W Performance

KPTI-89.7%

TPST-93.1%

YTD Performance

KPTI-91.6%

TPST-74.2%

% from 52W High

KPTI-94.5%

TPST-93.8%

% from 52W Low

KPTI7.1%

TPST2.3%

Asset Turnover (TTM)

KPTI1.31x

TPST0.01x

FCF Yield (TTM)

KPTI-476.7%

TPST-170.7%

Earnings Yield (TTM)

KPTI-1639.3%

TPST-333.2%

Dividend Yield (TTM)

KPTIN/A

TPSTN/A

Rule of 40

KPTI-37.8

TPST-6.3

EV/GP/RG

KPTI0.07

TPSTN/A

Ticker research

View KPTI research View TPST research

Metric	KPTI Karyopharm Therapeutics Inc	TPST Tempest Therapeutics Inc
Market & Valuation
Market Cap	$14M	$12M
Enterprise Value	$281M	$11M
Price	$0.61	$0.76
P/E Ratio	N/A	N/A
P/S Ratio	0.09x	45.67x
EV/Sales	1.92x	43.07x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.36x	16.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.30x	-0.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.10x	N/A
Revenue & Growth
Revenue (TTM)	$147M	$0
Revenue Growth (YoY)	6.8%	-6.3%
Forward Rev Growth	27.7%	0.0%
Profitability
Gross Margin (TTM)	95.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-56.1%	0.0%
Net Margin (TTM)	-153.3%	0.0%
FCF Margin (TTM)	-44.6%	N/A
Net Income (TTM)	$-225M	$-40M
FCF (TTM)	$-65M	$-21M
EPS (TTM)	-$7.77	-$2.66
ROE (TTM)	-18243.0%	-72989.0%
ROA (TTM)	-20094.0%	-29736.0%
ROIC (TTM)	-6632.0%	-72989.0%
Financial Health
Cash	$55M	$779K
Debt	$322M	$0
Net Cash/Debt	$-267M	$779K
Current Ratio (TTM)	0.79x	0.38x
Quick Ratio (TTM)	0.71x	0.27x
Debt/Equity (TTM)	3.78x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.14	-1.61
52W Performance	-89.7%	-93.1%
YTD Performance	-91.6%	-74.2%
% from 52W High	-94.5%	-93.8%
% from 52W Low	7.1%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	1.31x	0.01x
FCF Yield (TTM)	-476.7%	-170.7%
Earnings Yield (TTM)	-1639.3%	-333.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-37.8	-6.3
EV/GP/RG	0.07	N/A
Ticker research	View KPTI research	View TPST research